Actor
iOnctura SA
Late stage preclinical biotechnology company developing a pipeline of next generation for the treatment of cancer and fibrosis. Programs in oncology aim to harness both immune-mediated and direct anti-tumour activity to deliver superior clinical efficacy in monotherapy or combinations. By building on complementary mechanisms between cancer and fibrosis, iOnctura further aims to address high unmet need in fibrotic disease.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.00 Antibodies & Anti-infectious
1.10 Small Molecules
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Immunology & Allergy, Oncology
Main sector
Biotech
Contact
Avenue de Sécheron 15
1202 Geneva / GE